Joseph Edelman

Joseph Edelman

Founder bei ARYA SCIENCES ACQUISITION CORP V

Vermögen: 7 Mio $ am 31.03.2024

67 Jahre
Finance
Health Technology
Consumer Services

Profil

Joseph Eric Edelman is the founder of Perceptive Advisors LLC, which was founded in 1999.
He holds the title of Chief Executive Officer & Portfolio Manager at Perceptive Advisors LLC.
He is also the founder of Perceptive Advisors (Private Equity), which was founded in 1999.
He holds the title of Chief Executive Officer & Portfolio Manager at Perceptive Advisors (Private Equity).
In addition, Mr. Edelman is the founder of ARYA Sciences Acquisition Corp., which was founded in 2018.
He held the title of Chairman at ARYA Sciences Acquisition Corp.
from 2018 to 2020.
He is also the founder of ARYA Sciences Acquisition Corp.
II, which was founded in 2020.
He held the title of Chairman at ARYA Sciences Acquisition Corp.
II in 2020.
Furthermore, Mr. Edelman is the founder of ARYA Sciences Acquisition Corp.
III, which was founded in 2020.
He held the title of Chairman at ARYA Sciences Acquisition Corp.
III from 2020 to 2021.
He is previously the founder and Chairman of ARYA Sciences Acquisition Corp.
IV, which was founded in 2020.
He is also the founder and Chairman of ARYA Sciences Acquisition Corp.
V, which was founded in 2021.
Mr. Edelman's current job(s) include being an Independent Director at Athira Pharma, Inc. since 2020 and a Director at Xontogeny LLC.
Mr. Edelman's former job(s) include being a Director at Penwest Pharmaceuticals Co. from 2009 to 2010.
He also worked as a Senior Analyst at Paramount BioCapital Asset Management, Inc. and as a Senior Biotechnology Analyst at Prudential Securities.
Additionally, he worked as a Biotechnology Analyst at Martin Simpson & Co., Inc.Mr. Edelman's education history includes obtaining an MBA degree from New York University in 1986 and an undergraduate degree from the University of California San Diego in 1980.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
25.04.2023 170 317 ( 0,09% ) 7 Mio $ 31.03.2024
19.05.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Joseph Edelman

UnternehmenPositionBeginn
ATHIRA PHARMA, INC. Director/Board Member 01.05.2020
ARYA SCIENCES ACQUISITION CORP IV Founder 24.08.2020
ARYA SCIENCES ACQUISITION CORP V Founder 22.02.2021
Chief Executive Officer 01.01.1999
Chief Executive Officer 01.01.1999
Director/Board Member -
Alle aktiven Positionen von Joseph Edelman

Ehemalige bekannte Positionen von Joseph Edelman

UnternehmenPositionEnde
ARYA SCIENCES ACQUISITION III A Founder 01.06.2021
CEREVEL THERAPEUTICS HOLDINGS, INC. Founder 01.10.2020
ARYA SCIENCES ACQUISITION III A Founder 01.06.2020
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Sehen Sie sich die Erfahrung von Joseph Edelman im Detail an

Ausbildung von Joseph Edelman

New York University Masters Business Admin
University of California San Diego Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Joseph Edelman im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
ATHIRA PHARMA, INC.

Health Technology

ARYA SCIENCES ACQUISITION CORP IV

Finance

Private Unternehmen11

Finance

Health Technology

Prudential Securities

Finance

Finance

Martin Simpson & Co., Inc.

Finance

Health Technology

Finance

Finance

Finance

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Joseph Edelman